Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Allergy is a specialized biotechnology and diagnostics company focused on the development and commercialization of advanced allergy testing solutions. The company utilizes Component-Resolved Diagnostics (CRD) to provide high-resolution mapping of a patient's allergic sensitization profile at the molecular level. By identifying specific allergenic proteins rather than just whole extracts, Global Allergy's products enable clinicians to differentiate between true primary sensitization and cross-reactivity. This precision approach supports more accurate risk assessment for severe systemic reactions and informs the selection of targeted immunotherapy. The company's services are primarily utilized by allergists and clinical laboratories to improve the management of food and respiratory allergies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global Allergy.